University of Minnesota
Investigation of Molecular Therapeutic Targets in Malignant Peripheral Nerve Sheath Tumors
Abstract
dc:description.abstractMalignant peripheral nerve sheath tumors (MPNSTs) are aggressive softtissue sarcomas that commonly arise in patients with Neurofibromatosis Type I (NF1) syndrome. These tumors primarily follow a genetic etiology of successive tumor suppressor loss; first, loss of NF1, followed by loss of CDKN2A or TP53, and finally loss of SUZ12 or EED that leads to loss of polycomb repressor complex 2 (PRC2) activity. Despite a wealth of knowledge regarding the genetic events preceding MPNST development, therapeutic interventions have consistently failed to deliver durable responses in patients. Additionally, the specific molecular effects from PRC2 loss are still not well characterized. In the work described herein, we develop two individual efforts to further characterize the molecular landscape of PRC2-deficient MPNSTs. First, we utilize cell surface proteomics to understand what antigens are consistently present on the surface of MPNST model systems and probe model systems with and without PRC2 activity to identify antigens regulated by PRC2. In doing so, we identify several antigens that serve as promising therapeutic targets, as well as one novel antigen, PTK7, that produces consistent therapeutic response in our models. Second, we use HiC, a method to study 3D genomic architecture, to understand the structural genomic landscape of MPNST and how this structure begets oncogene activation. In doing so, we uncover various structural variants and formation of “neoloops” that signal potential oncogene activity. These efforts show the use of newly developed tools to further characterize MPNST as well as discover promising targets for therapeutic assault.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Stehn, Christopher Michael
Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Citation
- Stehn, Christopher Michael. (2026). Investigation of Molecular Therapeutic Targets in Malignant Peripheral Nerve Sheath Tumors. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/283154.